Remel Recalls Oxoid Vancomycin Susceptibility Discs Due to Impregnation Defect
Remel Inc is recalling Oxoid Vancomycin 30 mcg susceptibility discs because some may lack the antibiotic, potentially affecting in-vitro testing results.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences, or where the probability of serious adverse health consequences is remote. No injuries or illnesses are reported in the source text.
Plain-English summary
Remel Inc is voluntarily recalling Oxoid Vancomycin 30 mcg susceptibility discs, product code CT0058B. The recall involves 40/5/50-disc cartridge packages from Lot 1174497, which have an expiration date of 2015/04. These products were distributed nationwide.
The recall is being issued because some of the discs may not be impregnated with the antibiotic. These discs are used in the semi-quantitative agar diffusion test method for in-vitro susceptibility testing. The label identifies the firm as Oxoid Ltd., Basingstoke, Hampshire, England.
The FDA has classified this as a Class II recall. Users should stop using the affected lots and contact Remel Inc for further instructions or a replacement.
The recalled product
- Product
- Oxoid Vancomycin 30 mcg, each cartridge contains 50 susceptibility discs, CT0058B. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England. Used in the semi-quantitative agar diffusion test method for in-vitro susceptibility testing.
- Manufacturer
- Remel Inc
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 1174497
- exp. 2015/04
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Remel Inc
See all →- HighGC Agar Base Culture Media Reduced Recovery of Neisseria gonorrhoeae
FDA (Devices) · 2026-07-08
- HighYeastone Broth recalled because it may report incorrect susceptibility results
FDA (Devices) · 2026-04-22
- SevereRemel Campy CVA Medium Lot Recalled Over Low Pathogen Recovery
FDA (Devices) · 2026-03-04
- ModerateCulture media recalled over contamination that may darken the broth
FDA (Devices) · 2025-12-03
- HighStrep Selective II Agar plates may carry Listeria monocytogenes contamination
FDA (Devices) · 2025-08-06
Same hazard · defective product
See all →- HighSABRE Aim & Fire Pepper Gel Spray Canisters Failure to Deploy
CPSC · 2023-12-07
- HighOssur Recalls Multiple Orthopedic Braces and Medical Devices
FDA (Devices) · 2016-04-06
Similar recalls
- ModerateRemel Recalls Oxoid Antimicrobial Susceptibility Testing Discs Due to Impregnation Defect
FDA (Devices) · 2014-01-22
- ModerateRemel Recalls Oxoid Cefpodoxime Antimicrobial Susceptibility Test Discs
FDA (Devices) · 2014-01-29
- ModerateRemel Recalls Oxoid Ampicillin Test Discs Due to Missing Antibiotic
FDA (Devices) · 2014-01-29
- ModerateRemel Recalls Oxoid Norfloxacin Antimicrobial Susceptibility Test Discs
FDA (Devices) · 2014-01-29
- ModerateRemel Recalls Oxoid Ertapenem Antimicrobial Susceptibility Test Discs
FDA (Devices) · 2014-01-29
- LowRemel Recalls Oxoid Nitrofurantoin Antimicrobial Susceptibility Test Discs
FDA (Devices) · 2013-09-04